Locally injected dexmedetomidine induces vasoconstriction via peripheral α-2A adrenoceptor subtype in guinea pigs

Regional Anesthesia and Pain Medicine

Volumn 39, Issue 2, 2014, Pages 133-136

  Yabuki, Akiko ^a   Higuchi, Hitoshi ^b   Yoshitomi, Tatsushi ^c   Tomoyasu, Yumiko ^a   Ishii Maruhama, Minako ^b   Maeda, Shigeru ^b   Miyawaki, Takuya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c Kyoritsu Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; BLOOD FLOW VELOCITY; DEXMEDETOMIDINE; GUINEA PIGS; INJECTIONS, SUBCUTANEOUS; MALE; RECEPTORS, ADRENERGIC, ALPHA-2; VASOCONSTRICTION;

EID: 84894451174     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0000000000000048     Document Type: Article

References (19)

1. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent. 2001;14:13-21.
2. Kamibayashi T, Maze M. Clinical uses of α2-adrenergic agonists. Anesthesiology. 2000;93:1345-1349.
3. Brummett CM, Norat MA, Palmisano JM, Lydic R. Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in the rat. Anesthesiology. 2008;109:502-511.
4. Brummett CM, Padda AK, Amodeo FS, Welch KB, Lydic R. Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. Anesthesiology. 2009;111:1111-1119.
5. Saadawy I, Boker A, Elshahawy MA, et al. Effect of dexmedetomidine on the characteristics of bupivacaine in a caudal block in pediatrics. Acta Anaesthesiol Scand. 2009;53:251-256.
6. Esmaoglu A, Yegenoglu F, Akin A, Turk CY. Dexmedetomidine added to levobupivacaine prolongs axillary brachial plexus block. Anesth Analg. 2010;111:1548-1551.
7. Brummett CM, Hong EK, Janda AM, Amodeo FS, Lydic R. Peripheral dexmedetomidine added to ropivacaine for sciatic nerve block in rats prolongs the duration of analgesia by blocking the hyperpolarization-activated cation current. Anesthesiology. 2011;115:836-843.
8. Brummett CM, Amodeo FS, Janda AM, Padda AK, Lydic R. Peripheral dexmedetomidine provides an increased duration of analgesia to a thermal stimulus when compared with a systemic control in a rat sciatic nerve block. Reg Anesth Pain Med. 2010;35:427-431.
9. Yoshitomi T, Kohjitani A, Maeda S, Higuchi H, Shimada M, Miyawaki T. Dexmedetomidine enhances the local anesthetic action of lidocaine via an α-2? adrenoceptor. Anesth Analg. 2008;107:96-101.
10. MacKinnon AC, Spedding M, Brown CM. α2-Adrenoceptors: more subtypes but fewer functional differences. Trends Pharmacol Sci. 1994;15:119-123.
11. Link RE, Desai K, Hein L, et al. Cardiovascular regulation in mice lacking α2-adrenergic receptor subtypes b and c. Science. 1996;273:803-805.
12. Duka I, Gavras I, Johns C, Handy DE, Gavras H. Role of the postsynaptic α2-adrenergic receptor subtypes in catecholamine-induced vasoconstriction. Gen Pharmacol. 2000;34:101-106.
13. Gyires K, Zadori Z, Torok T, Matyus P. α2-Adrenoceptor subtypes-mediated physiological, pharmacological actions. Neurochem Int. 2009;55:447-453.
14. Virtanen R, Savola J-M, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:9-14.
15. MacDonald E, Kobilka BK, Scheinin M. Gene targeting-homing in on alpha2-adrenoceptor-subtype function. Trends Pharmacol Sci. 1997;18:211-219.
16. Calzada BC, De Artinano AA. Alpha-adrenoceptor subtypes. Pharmacol Res. 2001;44:195-208.
17. Angus JA, Cocks TM, Satoh K. The α adrenoceptors on endothelial cells. Fed Proc. 1986;45:2355-2359.
18. Hamasaki J, Tsuneyoshi I, Katai R, Hidaka T, Boyle WA, Kanmura Y. Dual α2-adrenergic agonist and α1-adrenergic antagonist actions of dexmedetomidine on human isolated endothelium-denuded gastroepiploic arteries. Anesth Analg. 2002;94:1434-1440.
19. Kosugi T, Mizuta K, Fujita T, Nakashima M, Kumamoto E. High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without α2 adrenoceptor activation. Br J Pharmacol. 2010;160:1662-1676.